Tuberculosis

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It spreads through airborne droplets from people with active disease (McHenry ML et al. (2020)). TB remains the deadliest infectious disease worldwide, with an estimated 10.7 million people falling ill and 1.23 million deaths in 2024. About a quarter of the world’s population is estimated to carry a latent infection, but most people exposed to the bacterium never develop active disease (McHenry ML et al. (2020)).

After exposure, the bacterium may be cleared by the immune system, persist as a latent infection, or progress to active disease (Drain PK et al. (2018)). TB most often affects the lungs, causing a persistent cough, fever, night sweats and weight loss (Furin J et al. (2019)). HIV infection, undernutrition, diabetes and smoking increase the risk of developing active disease. Drug-susceptible TB is curable with a standard 6-month regimen based on rifampicin, isoniazid, pyrazinamide and ethambutol, while drug-resistant TB needs different regimens (Furin J et al. (2019)).

Differential abundance and machine learning analysis

This section presents the disease-specific results of the differential abundance and machine learning analyses. The analyses are reported for three comparisons: 1) disease vs. all other diseases, 2) disease vs. diseases from the same class, and 3) disease vs. healthy samples.

DIFFERENTIAL ABUNDANCE AND MACHINE LEARNING ANALYSIS
Technology
Olink Explore HT
SomaScan 11K
Comparison
Disease vs All other
Disease vs Class
Disease vs Healthy

COMPARE TECHNOLOGIES FOR THIS DISEASE
Fold change per technology · most differentially abundant proteins across technologies ·
Concordance: Olink HT vs SomaScan ·